Protalix BioTherapeutics
PLX
#9005
Rank
ยฃ0.15 B
Marketcap
ยฃ1.98
Share price
0.00%
Change (1 day)
41.62%
Change (1 year)

EPS for Protalix BioTherapeutics (PLX)

EPS in 2026 (TTM): ยฃ0.16

According to Protalix BioTherapeutics 's latest financial reports the company's current EPS (TTM) is ยฃ0.16. In 2025 the company made an earnings per share (EPS) of -ยฃ0.05958 a decrease over its 2024 EPS that were of ยฃ0.02979.

EPS history for Protalix BioTherapeutics from 1996 to 2026

Annual EPS

Year EPS Change
2026 (TTM)ยฃ0.16-364%
2025-ยฃ0.05958-300%
2024ยฃ0.02979-66.67%
2023ยฃ0.08937-138.71%
2022-ยฃ0.23-50%
2021-ยฃ0.46181.82%
2020-ยฃ0.16-82.11%
2019-ยฃ0.92-31.67%
2018-ยฃ1.34-72.31%
2017-ยฃ4.84124.14%
2016-ยฃ2.16-147.54%
2015ยฃ4.54-290.63%
2014-ยฃ2.386.67%
2013-ยฃ2.23130.77%
2012-ยฃ0.97-69.77%
2011-ยฃ3.2019.44%
2010-ยฃ2.68-12.2%
2009-ยฃ3.0536.67%
2008-ยฃ2.23-37.5%
2007-ยฃ3.5750%
2006-ยฃ2.383.23%
2005-ยฃ2.31138.46%
2004-ยฃ0.97-74%
2003-ยฃ3.72-0%
2002-ยฃ3.72-50%
2001-ยฃ7.45233.33%
2000-ยฃ2.23-84.21%
1999-ยฃ14.15-24%
1998-ยฃ18.62-600%
1997ยฃ3.72-16.67%
1996ยฃ4.47

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
ยฃ0.98 523.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
ยฃ5.00 3,095.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
-ยฃ0.08192-152.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ1.02 552.38%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel